Tanzania
Health
Saving Mothers' Lives in Rural Tanzania
Actions
Share & SaveMore Information About this ProjectProject Needs and BeneficiariesEach year, twice as many women die in childbirth as people who died in the 2004 tsunami. 99% of these deaths are in developing countries and hemorrhage is the most common cause worldwide. Bleeding can be controlled in a clinic, but we have shown that traditional midwives can use inexpensive misoprostol tablets to save lives in a woman’s home. This is where most births take place and most maternal deaths occur in the developing world--well beyond reach of hospitals and government health services. ActivitiesWe help create a sustainable market for misoprostol by working with local businesses who resell it at a small profit. We work with manufacturers, assist with the regulatory process, co-sponsor policy meetings and develop educational materials. Funding InformationTotal Funding Received to Date: $10,798 Additional DocumentationThis project has provided additional documentation in a PDF file (projdoc.pdf). ResourcesWhy this Project is ImportantPotential Long Term ImpactThe project is uniquely scalable. Tanzania has been unable to lower maternal death rates to meet the U.N.'s 2015 goal of 75% reduction. With this drug, traditional midwives get their first effective technology and see a major reduction in mortality. Project Message
When we started training for the Kigoma project, word spread. Pregnant women who knew their lives were in danger traveled 70km when they heard that we had a drug to stop bleeding after childbirth. Who is Running This ProjectContact
Amy Grossman, Project SponsorOrganization
Learn more about Venture Strategies for Health and Development and the project team. Venture Strategies for Health and Development's Current Projects on GlobalGiving
Where this Project is LocatedCountry
This project is located in For more information about Tanzania, read the Human Development Report on Tanzania or the Wikipedia entry for Tanzania. When this Project was UpdatedLast UpdatedThis project was last updated on June 10, 2008. Date Added to GlobalGivingThis project was added to the GlobalGiving project catalog on September 02, 2005. Latest Update from the FieldReaching pregnant women with misoprostolBy Amy Grossman - Communications Manager, June 10, 2008 06:46 PM In Tanzania there is near universal attendance for at least one antenatal care visit (96%), yet the majority of births still take place at home. Antenatal care visits may prove to be a key contact point to reach vulnerable women with safe birthing messages and misoprostol for prevention. With partners at the local Ifakara Research and Development Center, VSHD has designed and is funding a critical project to evaluate the feasibility and acceptability of distribution of misoprostol tablets directly to women at antenatal care visits for the prevention of PPH. This innovative model is expected to reach a large number of women with the life-saving tablets. The results of this study will generate evidenced-based recommendations to inform policy decisions on community access to the tablets and scale-up efforts in Tanzania and beyond. Read 4 more "Updates from the Field" | Comment on this update How Else You Can HelpSpread the Word on your Profile, Blog, or WebsitePut a widget for this project on your profile, blog or website to turn your friends into givers. Using our widget, it's quick and easy to add this widget to your profile or blog! Get this widget on: |
||||||||||||||
Please help improve GlobalGiving.com
by answering just 3 questions
when you finish your visit.
